Evidence map›Paper›PMID 38393080›Full record

ArticleVeterinary sciences2024

Examination of the Virulence of

Miklós Tenk, Gergely Tóth, Zsuzsanna Márton, Rita Sárközi, Alejandra Szórádi, László Makrai, Nimród Pálmai, Tamás Szalai, Mihály Albert, László Fodor

Abstract read
In one paragraph

Article in Veterinary sciences, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Miklós TenkCEVA-Phylaxia Veterinary Biologicals Co., Ltd., Szállás u. 5, H-1107 Budapest, Hungary.
Gergely TóthDepartment of Microbiology and Infectious Diseases, University of Veterinary Medicine, Hungária Krt. 23-25, H-1143 Budapest, Hungary.
Zsuzsanna MártonCEVA-Phylaxia Veterinary Biologicals Co., Ltd., Szállás u. 5, H-1107 Budapest, Hungary.
Rita SárköziDepartment of Microbiology and Infectious Diseases, University of Veterinary Medicine, Hungária Krt. 23-25, H-1143 Budapest, Hungary.
Alejandra SzórádiCEVA-Phylaxia Veterinary Biologicals Co., Ltd., Szállás u. 5, H-1107 Budapest, Hungary.
László MakraiDepartment of Microbiology and Infectious Diseases, University of Veterinary Medicine, Hungária Krt. 23-25, H-1143 Budapest, Hungary.
Nimród PálmaiCEVA-Phylaxia Veterinary Biologicals Co., Ltd., Szállás u. 5, H-1107 Budapest, Hungary.
Tamás SzalaiCEVA-Phylaxia Veterinary Biologicals Co., Ltd., Szállás u. 5, H-1107 Budapest, Hungary.
Mihály AlbertCEVA-Phylaxia Veterinary Biologicals Co., Ltd., Szállás u. 5, H-1107 Budapest, Hungary.
László FodorDepartment of Microbiology and Infectious Diseases, University of Veterinary Medicine, Hungária Krt. 23-25, H-1143 Budapest, Hungary.ORCID 0000-0003-2711-0229

Funding

National Research, Developme4nt and Innovation Office OTKA 132833
6 · The paper itself

Abstract

Different virulence variants of

Indexed as

Actinobacillus pleuropneumoniaechallengeserovar 16

Identifiers

PMID38393080
PMCPMC10892955

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.